All In Biotech

Free tool

FAERS Monitor: Chromic Chloride In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018961 or its brand name (Chromic Chloride In Plastic Container, Chromic Chloride). Reports on generic versions are filed under their own applications.

Reports

861

Serious

472

55% of reports

Hospitalization

186

Death reported

25

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue101
  • nausea88
  • diarrhoea82
  • headache72
  • pain66
  • drug ineffective65
  • dizziness54
  • arthralgia53
  • asthenia52
  • weight decreased51
  • insomnia48
  • fall45
  • cough43
  • malaise43
  • vomiting41

Reports by year received

View as table
YearReports
200427
200516
200617
200718
200822
200923
201010
20117
201221
201333
201445
201578
201674
201764
201864
201951
202064
202138
202239
202345
202440
202530
202635

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,298 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
weight decreasedSignal514.53.4135
insomniaSignal484.43.3124
coughSignal433.72.885
astheniaSignal523.42.686
fallSignal453.32.571
fatigueSignal1013.22.6153
arthralgiaSignal533.12.475
diarrhoeaSignal823.12.5118
headacheSignal722.82.284
nauseaSignal882.72.297
dizzinessSignal542.62.055
painSignal662.62.167
malaiseSignal432.41.834
vomitingSignal412.11.624
drug ineffective651.21.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.